• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Tetracycline labeling of bone in vivo.

作者信息

Tam C S, Anderson W

出版信息

Calcif Tissue Int. 1980;30(2):121-5. doi: 10.1007/BF02408616.

DOI:10.1007/BF02408616
PMID:6155183
Abstract

We have analyzed various aspects of tetracycline labeling technique for the measurement of bone apposition rate in vivo. Our efforts were restricted to those aspects that are frequently questioned when data obtained using this technique are interpreted as representing the rate of bone apposition. Rat bone was labeled in vivo by sequential injections of oxytetracycline at a dose range of 3 to 24 mg/kg body weight and at intervals ranging from 24 to 72 h. The bone apposition rate was calculated by measuring the distance from the first dose of label to the subsequent ones. As these distances are by far too small to be determined accurately by any available micrometer eyepiece, we have used a scanning microscope photometer which allows measurements on slow-forming sites that otherwise would have been considered nongrowing sites. Using these techniques, we have demonstrated that oxytetracycline has no effect on the bone apposition rate when used in the concentrations indicated. In addition, we found that at labeling intervals of 96 h or more, periods of osteoblastic inactivity are likely to be included in measurements at individual sites. The instantaneous apposition rate is thus underestimated at these long time intervals.

摘要

相似文献

1
Tetracycline labeling of bone in vivo.
Calcif Tissue Int. 1980;30(2):121-5. doi: 10.1007/BF02408616.
2
Difference in label length between demethylchlortetracycline and oxytetracycline: implications for the interpretation of bone histomorphometric data.
Calcif Tissue Int. 1991 Feb;48(2):74-7. doi: 10.1007/BF02555869.
3
Tetracyclines inhibit rat osteoclast formation and activity in vitro and affect bone turnover in young rats in vivo.四环素类药物在体外抑制大鼠破骨细胞的形成和活性,并影响幼年大鼠体内的骨转换。
Calcif Tissue Int. 2010 Feb;86(2):163-71. doi: 10.1007/s00223-009-9328-5. Epub 2009 Dec 23.
4
Bone apposition rate as an index of bone metabolism.骨沉积率作为骨代谢的一个指标。
Metabolism. 1978 Feb;27(2):143-50. doi: 10.1016/0026-0495(78)90160-9.
5
Protective effect on vitamin D2 on bone apposition from the inhibitory action of hydrocortisone in rats.维生素D2对氢化可的松在大鼠体内抑制骨附着作用的保护效应。
Calcif Tissue Int. 1981;33(2):167-72. doi: 10.1007/BF02409430.
6
Oxytetracycline-induced nephrotoxicosis in dogs after intravenous administration for experimental bone labeling.静脉注射土霉素用于实验性骨标记后犬的土霉素诱导的肾毒性
Lab Anim Sci. 1996 Oct;46(5):497-502.
7
Inhibition of cortical and trabecular bone formation in the long bones of immobilized monkeys.固定不动的猴子长骨中皮质骨和小梁骨形成受到抑制。
Clin Orthop Relat Res. 1983 Dec(181):269-76.
8
The effect of vitamin D restriction and repletion on bone apposition in the rat and its dependence on parathyroid hormone.
Endocrinology. 1981 Nov;109(5):1448-53. doi: 10.1210/endo-109-5-1448.
9
A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: early actions of teriparatide.一种用于通过单次髂嵴骨活检纵向评估合成代谢疗法短期效果的新型四环素标记方案:特立帕肽的早期作用
J Bone Miner Res. 2006 Mar;21(3):366-73. doi: 10.1359/JBMR.051109. Epub 2005 Nov 21.
10
An automatic microspectrophotometric scanning method for the measurement of bone formation rates in vivo.一种用于体内测量骨形成率的自动显微分光光度扫描方法。
Calcif Tissue Int. 1980;32(1):63-8. doi: 10.1007/BF02408522.

引用本文的文献

1
The cellular effect of intermittent PTH treatment on bone remodeling and modeling in humans-a histomorphometry centered scoping review.间歇性甲状旁腺激素治疗对人体骨重塑和骨建模的细胞效应——一项以组织形态计量学为核心的综述
Osteoporos Int. 2025 Sep 9. doi: 10.1007/s00198-025-07612-z.
2
Bone Targeting Nanoparticles for the Treatment of Osteoporosis.靶向骨的纳米粒子治疗骨质疏松症。
Int J Nanomedicine. 2024 Feb 12;19:1363-1383. doi: 10.2147/IJN.S444347. eCollection 2024.
3
Bone-Targeted Nanoparticle Drug Delivery System: An Emerging Strategy for Bone-Related Disease.

本文引用的文献

1
CELL POPULATION KINETICS OF AN OSTEOGENIC TISSUE. II.成骨组织的细胞群体动力学。II。
J Cell Biol. 1963 Oct;19(1):33-44. doi: 10.1083/jcb.19.1.33.
2
CELL POPULATION KINETICS OF AN OSTEOGENIC TISSUE. I.成骨组织的细胞群体动力学。I.
J Cell Biol. 1963 Oct;19(1):19-32. doi: 10.1083/jcb.19.1.19.
3
Cell proliferation and specialization during endochondral osteogenesis in young rats.幼鼠软骨内成骨过程中的细胞增殖与分化
骨靶向纳米颗粒药物递送系统:一种治疗骨相关疾病的新兴策略
Front Pharmacol. 2022 May 31;13:909408. doi: 10.3389/fphar.2022.909408. eCollection 2022.
4
YAP and TAZ Promote Periosteal Osteoblast Precursor Expansion and Differentiation for Fracture Repair.YAP和TAZ促进骨膜成骨细胞前体的扩增和分化以修复骨折
J Bone Miner Res. 2021 Jan;36(1):143-157. doi: 10.1002/jbmr.4166. Epub 2020 Oct 7.
5
In vivo Labeling of Bone Microdamage in an Animal Model of Type 1 Diabetes Mellitus.1 型糖尿病动物模型中骨微损伤的体内标记。
Sci Rep. 2019 Nov 18;9(1):16994. doi: 10.1038/s41598-019-53487-6.
6
Biomaterial-assisted local and systemic delivery of bioactive agents for bone repair.生物材料辅助的生物活性物质局部和全身递送用于骨修复。
Acta Biomater. 2019 Jul 15;93:152-168. doi: 10.1016/j.actbio.2019.01.060. Epub 2019 Jan 31.
7
Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee.骨组织形态计量学的标准化命名、符号和单位:美国骨矿研究学会(ASBMR)组织形态计量学命名委员会2012年报告更新版
J Bone Miner Res. 2013 Jan;28(1):2-17. doi: 10.1002/jbmr.1805.
8
Protective effect on vitamin D2 on bone apposition from the inhibitory action of hydrocortisone in rats.维生素D2对氢化可的松在大鼠体内抑制骨附着作用的保护效应。
Calcif Tissue Int. 1981;33(2):167-72. doi: 10.1007/BF02409430.
9
A model of osteon closure in cortical bone.
Calcif Tissue Int. 1990 Nov;47(5):261-9. doi: 10.1007/BF02555907.
10
Normal bone particles are preferentially resorbed in the presence of osteocalcin-deficient bone particles in vivo.在体内,正常骨颗粒在存在骨钙素缺陷的骨颗粒时会优先被吸收。
Calcif Tissue Int. 1991 Jul;49(1):43-50. doi: 10.1007/BF02555901.
J Cell Biol. 1962 Sep;14(3):357-70. doi: 10.1083/jcb.14.3.357.
4
Variations in rate of human osteon formation.
Can J Biochem Physiol. 1963 Jan;41:19-22.
5
Tetracycline labelling of bone and the zone of demarcation of osteoid seams.
Can J Biochem Physiol. 1962 Apr;40:485-9.
6
Absorption and excretions studies on tetracycline.四环素的吸收与排泄研究。
J Pharmacol Exp Ther. 1959 Apr;125(4):287-94.
7
Blood levels and urinary excretion in normal subjects after ingestion of tetracycline analogues.正常受试者摄入四环素类似物后的血药浓度及尿排泄情况。
Proc Soc Exp Biol Med. 1954 Jan;85(1):61-5. doi: 10.3181/00379727-85-20785.
8
"Fractional labeling": the fraction of actively forming osteons that take tetracycline labels in normal human bone.“标记分数”:正常人体骨骼中摄取四环素标记的活跃形成骨单位的比例。
Henry Ford Hosp Med J. 1966 Sep;14(3):255-63.
9
Effect of tetracycline on collagen biosynthesis in cultured embryonic bones.
Biochem Pharmacol. 1969 Apr;18(4):827-36. doi: 10.1016/0006-2952(69)90053-7.
10
The inhibitory effect of tetracycline on osteogenesis in organ culture.四环素对器官培养中骨生成的抑制作用。
J Embryol Exp Morphol. 1970 Feb;23(1):185-211.